S-EPMC7298698 - Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). - OmicsDI

Unknown

Dataset Information

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).

ABSTRACT:

SUBMITTER: Neubauer A

PROVIDER: S-EPMC7298698 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets